| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
90,944 |
89,392 |
$8.19M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
4,720 |
3,600 |
$5.84M |
| 0450 |
Emergency room services |
73,512 |
70,936 |
$5.57M |
| Z7500 |
|
159,401 |
150,251 |
$5.42M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
100,342 |
94,233 |
$4.21M |
| 0113 |
|
1,738 |
1,711 |
$3.28M |
| 41899 |
Unlisted procedure, dentoalveolar structures |
1,498 |
1,455 |
$2.70M |
| 0123 |
|
1,207 |
1,193 |
$1.86M |
| 0510 |
|
40,799 |
36,534 |
$1.41M |
| 93325 |
|
9,579 |
9,259 |
$1.26M |
| 99199 |
Unlisted special service, procedure or report |
10,228 |
9,370 |
$1.00M |
| 90378 |
|
529 |
489 |
$929K |
| 0360 |
|
7,776 |
6,102 |
$836K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
20,598 |
18,954 |
$835K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,389 |
2,171 |
$809K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
462 |
433 |
$801K |
| 0710 |
|
8,170 |
7,822 |
$792K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
847 |
753 |
$690K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,223 |
3,168 |
$666K |
| Z7502 |
|
17,327 |
17,057 |
$661K |
| J0475 |
Injection, baclofen, 10 mg |
639 |
616 |
$619K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,924 |
2,861 |
$600K |
| 93303 |
Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study |
3,122 |
3,060 |
$573K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
58,180 |
51,667 |
$506K |
| 80053 |
Comprehensive metabolic panel |
37,526 |
33,855 |
$482K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
16,523 |
15,937 |
$439K |
| 0636 |
|
1,398 |
1,363 |
$428K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
1,414 |
1,397 |
$400K |
| 99499 |
|
7,570 |
6,571 |
$395K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
13,937 |
11,507 |
$384K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,445 |
2,216 |
$379K |
| 0760 |
|
58,408 |
53,430 |
$364K |
| 0250 |
|
5,266 |
4,018 |
$345K |
| J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg |
412 |
190 |
$344K |
| 93975 |
|
2,428 |
2,350 |
$342K |
| 72082 |
|
5,504 |
5,435 |
$336K |
| G9012 |
Other specified case management service not elsewhere classified |
661 |
613 |
$308K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
723 |
707 |
$303K |
| 0410 |
|
914 |
903 |
$301K |
| 93320 |
|
3,551 |
3,476 |
$273K |
| G0378 |
Hospital observation service, per hour |
7,060 |
6,726 |
$269K |
| 0301 |
|
1,864 |
1,810 |
$261K |
| 71046 |
Radiologic examination, chest; 2 views |
8,362 |
7,941 |
$259K |
| 76770 |
|
3,989 |
3,913 |
$254K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
22,131 |
6,471 |
$254K |
| V5298 |
Hearing aid, not otherwise classified |
185 |
185 |
$242K |
| 0456 |
|
5,190 |
5,033 |
$236K |
| Z5942 |
|
1,754 |
789 |
$224K |
| 92588 |
|
4,066 |
3,990 |
$213K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
15,458 |
6,143 |
$210K |
| 99221 |
|
2,766 |
2,639 |
$205K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,724 |
9,860 |
$199K |
| 95782 |
|
273 |
269 |
$189K |
| Z4307 |
|
3,584 |
3,565 |
$184K |
| 87631 |
|
3,071 |
3,029 |
$181K |
| 92700 |
|
2,239 |
2,162 |
$166K |
| 92557 |
|
2,371 |
2,306 |
$162K |
| 0370 |
|
408 |
390 |
$150K |
| 73090 |
|
5,158 |
4,190 |
$149K |
| J3490 |
Unclassified drugs |
10,664 |
7,276 |
$149K |
| 92567 |
|
6,699 |
6,586 |
$149K |
| 72170 |
|
5,095 |
4,994 |
$147K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
2,985 |
2,839 |
$144K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,284 |
2,191 |
$143K |
| 0258 |
|
2,398 |
2,351 |
$135K |
| 0306 |
|
1,519 |
1,486 |
$134K |
| X4300 |
|
1,322 |
1,299 |
$124K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,746 |
4,536 |
$121K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,259 |
2,175 |
$121K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
13,302 |
13,183 |
$117K |
| 73630 |
|
3,954 |
3,664 |
$116K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,643 |
1,469 |
$111K |
| 0320 |
|
1,441 |
1,414 |
$110K |
| 97799 |
|
8,000 |
2,992 |
$109K |
| 73610 |
|
4,100 |
3,758 |
$105K |
| 92523 |
|
1,698 |
1,641 |
$105K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
2,663 |
2,274 |
$102K |
| 73100 |
|
4,163 |
3,687 |
$102K |
| 84443 |
Thyroid stimulating hormone (TSH) |
10,697 |
10,503 |
$100K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,939 |
1,898 |
$100K |
| X4304 |
|
3,842 |
1,775 |
$99K |
| Z5924 |
|
1,622 |
1,609 |
$95K |
| 97750 |
|
4,552 |
3,375 |
$92K |
| X4303 |
|
1,729 |
934 |
$91K |
| 93304 |
|
856 |
830 |
$91K |
| 70450 |
Computed tomography, head or brain; without contrast material |
606 |
597 |
$88K |
| 93321 |
|
2,063 |
1,977 |
$85K |
| Z5958 |
|
449 |
428 |
$83K |
| Z7610 |
|
5,582 |
4,101 |
$81K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,874 |
1,673 |
$77K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,513 |
1,440 |
$77K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
755 |
727 |
$77K |
| 0272 |
|
2,316 |
2,197 |
$74K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,945 |
5,811 |
$74K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,779 |
2,561 |
$70K |
| 97763 |
|
1,900 |
963 |
$69K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,513 |
2,234 |
$68K |
| 0271 |
|
2,935 |
2,795 |
$68K |
| 74019 |
|
1,994 |
1,906 |
$66K |
| 73590 |
|
2,595 |
2,168 |
$66K |
| 97139 |
|
10,980 |
1,974 |
$66K |
| 73070 |
|
2,453 |
2,189 |
$65K |
| 93226 |
|
837 |
813 |
$64K |
| 80197 |
|
3,504 |
2,257 |
$64K |
| 74018 |
|
3,497 |
3,314 |
$64K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
11,316 |
10,663 |
$63K |
| Z4308 |
|
2,204 |
2,177 |
$62K |
| 73130 |
|
2,214 |
2,054 |
$62K |
| 73080 |
|
2,031 |
1,837 |
$61K |
| 86140 |
|
10,149 |
9,654 |
$61K |
| Z5916 |
|
1,362 |
1,357 |
$59K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
740 |
722 |
$59K |
| Z5910 |
|
1,547 |
1,501 |
$59K |
| 0402 |
|
301 |
298 |
$58K |
| 73140 |
|
3,339 |
3,022 |
$58K |
| 87799 |
|
799 |
643 |
$58K |
| 83735 |
|
7,531 |
6,049 |
$58K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
3,607 |
3,037 |
$58K |
| 94010 |
|
3,283 |
3,211 |
$57K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,625 |
8,083 |
$56K |
| 73110 |
|
2,057 |
1,954 |
$55K |
| 0305 |
|
1,696 |
1,665 |
$54K |
| 87581 |
|
2,854 |
2,804 |
$54K |
| 87486 |
|
2,854 |
2,804 |
$54K |
| 77073 |
|
1,436 |
1,355 |
$52K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
313 |
305 |
$52K |
| 97802 |
|
894 |
885 |
$50K |
| 76825 |
|
305 |
299 |
$48K |
| 93225 |
|
836 |
815 |
$47K |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
10,590 |
5,238 |
$46K |
| 82728 |
|
3,968 |
3,242 |
$45K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
145 |
144 |
$44K |
| 51741 |
|
2,206 |
2,031 |
$43K |
| 92521 |
|
1,051 |
1,033 |
$43K |
| 0302 |
|
1,171 |
1,155 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,299 |
1,109 |
$42K |
| Z5936 |
|
568 |
564 |
$42K |
| X3920 |
|
824 |
824 |
$41K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
973 |
481 |
$40K |
| 86003 |
|
1,893 |
1,765 |
$39K |
| 92508 |
Group treatment of speech, language, voice, communication, and/or auditory processing disorder |
3,436 |
1,357 |
$38K |
| 84100 |
|
6,963 |
5,572 |
$38K |
| Z4310 |
|
3,095 |
3,093 |
$37K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
8,049 |
4,378 |
$37K |
| 80061 |
Lipid panel |
9,979 |
9,819 |
$37K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
97 |
84 |
$36K |
| 97165 |
|
1,705 |
1,624 |
$36K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
1,140 |
1,131 |
$35K |
| 97010 |
|
4,703 |
2,171 |
$34K |
| 76870 |
|
650 |
641 |
$34K |
| 73620 |
|
804 |
734 |
$33K |
| Z4311 |
|
2,707 |
2,690 |
$32K |
| Z5406 |
|
2,613 |
2,610 |
$32K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,638 |
3,542 |
$31K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
774 |
728 |
$31K |
| J2704 |
Injection, propofol, 10 mg |
3,605 |
2,794 |
$31K |
| 73562 |
|
1,152 |
1,108 |
$30K |
| 76827 |
|
317 |
308 |
$29K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,285 |
3,200 |
$29K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,754 |
1,544 |
$29K |
| Z5914 |
|
128 |
127 |
$28K |
| 82784 |
|
3,516 |
3,315 |
$28K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,208 |
952 |
$28K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,936 |
1,821 |
$26K |
| 85652 |
|
8,879 |
8,493 |
$26K |
| Z7506 |
|
185 |
185 |
$26K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,514 |
1,436 |
$25K |
| 51784 |
|
374 |
325 |
$25K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
439 |
416 |
$25K |
| 82977 |
|
4,373 |
4,125 |
$24K |
| 92582 |
|
667 |
663 |
$24K |
| 87186 |
|
3,562 |
3,434 |
$24K |
| 85027 |
|
6,397 |
6,206 |
$24K |
| S0119 |
Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) |
864 |
781 |
$23K |
| 92587 |
|
410 |
383 |
$23K |
| 73060 |
|
135 |
119 |
$23K |
| 92579 |
|
1,009 |
1,003 |
$23K |
| Z4312 |
|
1,881 |
1,867 |
$23K |
| 73000 |
|
1,001 |
949 |
$23K |
| 87497 |
|
370 |
308 |
$22K |
| 83690 |
|
3,119 |
2,949 |
$22K |
| 77072 |
|
1,668 |
1,645 |
$22K |
| 73564 |
|
879 |
867 |
$22K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,741 |
1,651 |
$22K |
| 83970 |
|
387 |
383 |
$21K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
1,326 |
1,282 |
$21K |
| 84439 |
|
5,215 |
5,142 |
$21K |
| 82570 |
|
3,251 |
2,934 |
$21K |
| 51798 |
|
1,962 |
1,785 |
$21K |
| 84305 |
|
1,070 |
1,066 |
$20K |
| 95819 |
|
292 |
281 |
$20K |
| 93308 |
|
240 |
231 |
$19K |
| 83540 |
|
3,414 |
3,321 |
$19K |
| 87081 |
|
12,917 |
12,567 |
$18K |
| 0206 |
|
12 |
12 |
$18K |
| 12011 |
|
509 |
498 |
$18K |
| Z4302 |
|
1,144 |
1,144 |
$18K |
| 86480 |
|
383 |
380 |
$18K |
| 83550 |
|
3,067 |
2,983 |
$18K |
| 85045 |
|
4,318 |
3,895 |
$18K |
| Z5822 |
|
929 |
491 |
$17K |
| 64642 |
|
1,011 |
1,004 |
$17K |
| 0270 |
|
5,382 |
4,435 |
$17K |
| 82947 |
|
5,954 |
5,676 |
$17K |
| 0300 |
|
104 |
100 |
$17K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,109 |
2,049 |
$17K |
| 25600 |
|
1,127 |
1,054 |
$17K |
| X3908 |
|
659 |
232 |
$17K |
| 84436 |
|
3,227 |
3,159 |
$17K |
| V5264 |
Ear mold/insert, not disposable, any type |
337 |
336 |
$17K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,173 |
1,010 |
$17K |
| 99201 |
|
657 |
543 |
$16K |
| 95874 |
|
1,922 |
1,915 |
$16K |
| 87040 |
|
1,281 |
1,205 |
$16K |
| 64643 |
|
809 |
806 |
$16K |
| 81001 |
|
6,116 |
5,639 |
$16K |
| 82610 |
|
965 |
942 |
$15K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,429 |
2,293 |
$15K |
| 88300 |
|
1,574 |
1,530 |
$15K |
| 97803 |
|
452 |
420 |
$15K |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
1,963 |
1,885 |
$15K |
| 80076 |
|
2,257 |
2,161 |
$14K |
| 76885 |
|
172 |
170 |
$14K |
| 99218 |
|
78 |
77 |
$13K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
13 |
13 |
$13K |
| 85610 |
|
2,971 |
2,714 |
$13K |
| 73560 |
|
464 |
427 |
$13K |
| 96409 |
|
1,543 |
1,186 |
$13K |
| 83516 |
|
1,991 |
1,917 |
$13K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
91 |
91 |
$13K |
| 71045 |
Radiologic examination, chest; single view |
674 |
661 |
$13K |
| 85730 |
|
1,964 |
1,832 |
$12K |
| Z5908 |
|
276 |
262 |
$12K |
| 86355 |
|
1,018 |
919 |
$12K |
| 86359 |
|
1,020 |
921 |
$12K |
| J9370 |
Vincristine sulfate, 1 mg |
1,655 |
1,219 |
$12K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
277 |
274 |
$12K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
228 |
218 |
$11K |
| 81015 |
|
3,155 |
3,051 |
$11K |
| Z7514 |
|
193 |
158 |
$11K |
| 97116 |
|
655 |
340 |
$11K |
| 86360 |
|
996 |
899 |
$11K |
| 99243 |
|
361 |
278 |
$11K |
| Z5932 |
|
287 |
284 |
$11K |
| 96415 |
|
153 |
145 |
$11K |
| 87071 |
|
2,615 |
2,551 |
$11K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
155 |
130 |
$11K |
| 86357 |
|
980 |
884 |
$11K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
564 |
491 |
$10K |
| 84460 |
|
6,445 |
6,001 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
542 |
497 |
$10K |
| 87046 |
|
1,122 |
1,088 |
$10K |
| 0730 |
|
84 |
83 |
$10K |
| 87496 |
|
204 |
179 |
$9K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
901 |
865 |
$9K |
| X4542 |
|
196 |
194 |
$9K |
| 85384 |
|
856 |
800 |
$9K |
| 82670 |
|
229 |
227 |
$9K |
| 84156 |
|
2,445 |
2,129 |
$9K |
| X3910 |
|
545 |
192 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
471 |
450 |
$9K |
| 99070 |
|
836 |
594 |
$9K |
| Z5956 |
|
326 |
324 |
$8K |
| 82785 |
|
1,271 |
1,255 |
$8K |
| 81000 |
|
2,633 |
2,484 |
$8K |
| 0307 |
|
302 |
294 |
$8K |
| 84450 |
|
5,011 |
4,825 |
$8K |
| 73030 |
|
345 |
333 |
$7K |
| 73660 |
|
429 |
392 |
$7K |
| 0761 |
|
11,747 |
11,001 |
$7K |
| X4100 |
|
147 |
147 |
$7K |
| 17110 |
|
1,470 |
1,434 |
$7K |
| 81025 |
|
2,203 |
2,114 |
$7K |
| 86923 |
|
145 |
117 |
$7K |
| 99215 |
Prolong outpt/office vis |
219 |
164 |
$7K |
| 88304 |
|
652 |
635 |
$7K |
| 12001 |
|
242 |
239 |
$7K |
| T4534 |
Youth sized disposable incontinence product, protective underwear/pull-on, each |
39 |
39 |
$6K |
| X4110 |
|
272 |
155 |
$6K |
| 99460 |
|
91 |
91 |
$6K |
| 73551 |
|
198 |
189 |
$6K |
| 64644 |
|
41 |
41 |
$6K |
| G9920 |
Screening performed and negative |
381 |
381 |
$6K |
| 25605 |
|
159 |
154 |
$6K |
| 83615 |
|
885 |
710 |
$6K |
| 94060 |
|
195 |
193 |
$6K |
| 83002 |
|
716 |
713 |
$6K |
| X4500 |
|
68 |
68 |
$6K |
| 74455 |
|
79 |
79 |
$6K |
| Z5928 |
|
144 |
142 |
$5K |
| 87045 |
|
1,125 |
1,090 |
$5K |
| 29075 |
|
677 |
652 |
$5K |
| 87205 |
|
1,583 |
1,534 |
$5K |
| 86850 |
|
654 |
561 |
$5K |
| 42820 |
Tonsillectomy and adenoidectomy; younger than age 12 |
61 |
61 |
$5K |
| 92555 |
|
266 |
264 |
$5K |
| 83880 |
|
211 |
189 |
$5K |
| 86225 |
|
656 |
602 |
$5K |
| J7354 |
Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg) |
13 |
13 |
$5K |
| 87400 |
|
209 |
197 |
$5K |
| T4541 |
Incontinence product, disposable underpad, large, each |
170 |
168 |
$5K |
| V5267 |
Hearing aid or assistive listening device/supplies/accessories, not otherwise specified |
148 |
147 |
$5K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
69 |
60 |
$5K |
| 80180 |
|
287 |
208 |
$5K |
| 82139 |
|
190 |
167 |
$5K |
| L3260 |
Surgical boot/shoe, each |
96 |
96 |
$4K |
| 82550 |
|
679 |
653 |
$4K |
| Z5930 |
|
164 |
160 |
$4K |
| 82248 |
|
1,137 |
978 |
$4K |
| 93786 |
|
158 |
157 |
$4K |
| 99234 |
|
90 |
82 |
$4K |
| 85007 |
|
1,972 |
1,886 |
$4K |
| 87806 |
|
319 |
313 |
$4K |
| 82247 |
|
1,945 |
1,523 |
$4K |
| 72100 |
|
160 |
160 |
$4K |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
571 |
562 |
$4K |
| Z5906 |
|
77 |
72 |
$4K |
| 83655 |
|
6,911 |
6,824 |
$4K |
| 99462 |
|
106 |
86 |
$4K |
| 85048 |
|
995 |
896 |
$4K |
| Z7512 |
|
137 |
137 |
$4K |
| 99217 |
|
113 |
112 |
$3K |
| 73600 |
|
127 |
115 |
$3K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
478 |
435 |
$3K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
38 |
36 |
$3K |
| X4112 |
|
219 |
118 |
$3K |
| 97161 |
|
409 |
283 |
$3K |
| 76820 |
|
98 |
91 |
$3K |
| 86376 |
|
249 |
246 |
$3K |
| 84478 |
|
772 |
737 |
$3K |
| 86901 |
|
1,021 |
902 |
$3K |
| 82465 |
|
1,124 |
1,089 |
$3K |
| 95117 |
|
213 |
89 |
$3K |
| 86900 |
|
1,022 |
902 |
$3K |
| 83993 |
|
400 |
391 |
$3K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
1,009 |
861 |
$3K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
246 |
187 |
$3K |
| 84630 |
|
279 |
277 |
$3K |
| 83519 |
|
162 |
162 |
$3K |
| 82043 |
|
395 |
385 |
$3K |
| 83525 |
|
1,049 |
1,029 |
$3K |
| 84145 |
|
101 |
97 |
$3K |
| 93017 |
|
27 |
27 |
$3K |
| 86769 |
|
174 |
173 |
$3K |
| 26720 |
|
237 |
214 |
$3K |
| 99157 |
|
46 |
44 |
$3K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
64 |
46 |
$2K |
| 84403 |
|
466 |
466 |
$2K |
| 96367 |
|
51 |
46 |
$2K |
| 84446 |
|
149 |
148 |
$2K |
| 84550 |
|
515 |
474 |
$2K |
| 83021 |
|
357 |
326 |
$2K |
| 83001 |
|
332 |
312 |
$2K |
| E0570 |
Nebulizer, with compressor |
53 |
51 |
$2K |
| 29425 |
|
233 |
179 |
$2K |
| 29125 |
|
152 |
142 |
$2K |
| 94664 |
|
176 |
169 |
$2K |
| 00000 |
|
82 |
39 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
31 |
27 |
$2K |
| 82330 |
|
117 |
110 |
$2K |
| 76010 |
|
54 |
54 |
$2K |
| 84484 |
|
143 |
141 |
$2K |
| X4540 |
|
64 |
64 |
$2K |
| 86160 |
|
56 |
54 |
$2K |
| X4532 |
|
67 |
65 |
$2K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
254 |
234 |
$2K |
| 80230 |
|
53 |
53 |
$2K |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
13 |
13 |
$2K |
| 84590 |
|
107 |
107 |
$2K |
| 80299 |
|
80 |
77 |
$2K |
| 74230 |
|
26 |
26 |
$2K |
| 76377 |
|
15 |
15 |
$2K |
| 94680 |
|
29 |
29 |
$2K |
| 82565 |
|
1,450 |
1,128 |
$2K |
| 86665 |
|
110 |
108 |
$2K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
274 |
198 |
$1K |
| 95115 |
|
374 |
174 |
$1K |
| 82150 |
|
185 |
181 |
$1K |
| 96450 |
|
423 |
380 |
$1K |
| 98960 |
|
29 |
28 |
$1K |
| 86780 |
|
229 |
224 |
$1K |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
28 |
28 |
$1K |
| 87899 |
|
748 |
368 |
$1K |
| Z5922 |
|
25 |
25 |
$1K |
| Z5934 |
|
19 |
19 |
$1K |
| 29065 |
|
193 |
187 |
$1K |
| A4927 |
Gloves, non-sterile, per 100 |
182 |
180 |
$1K |
| 64640 |
|
17 |
17 |
$1K |
| 51600 |
|
78 |
78 |
$1K |
| J9260 |
Injection, methotrexate sodium, 50 mg |
733 |
468 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
866 |
579 |
$1K |
| 84480 |
|
101 |
101 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
64 |
55 |
$1K |
| 72070 |
|
27 |
24 |
$997.75 |
| 71020 |
|
102 |
66 |
$983.87 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
186 |
185 |
$979.50 |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
354 |
338 |
$897.75 |
| 24530 |
|
15 |
14 |
$887.93 |
| 70360 |
|
91 |
90 |
$880.46 |
| 86800 |
|
64 |
64 |
$862.61 |
| 82607 |
|
164 |
158 |
$853.66 |
| Z5968 |
|
26 |
26 |
$849.94 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
12 |
12 |
$836.40 |
| 93788 |
|
158 |
157 |
$828.41 |
| 85379 |
|
48 |
48 |
$799.29 |
| 94644 |
|
51 |
50 |
$776.95 |
| Z7508 |
|
13 |
13 |
$760.11 |
| Z4314 |
|
39 |
36 |
$748.02 |
| 80074 |
|
26 |
25 |
$741.40 |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
219 |
219 |
$719.99 |
| 51701 |
|
17 |
13 |
$718.29 |
| 82803 |
|
30 |
30 |
$691.38 |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
262 |
260 |
$655.04 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
315 |
309 |
$647.81 |
| 12002 |
|
25 |
25 |
$632.80 |
| 86664 |
|
109 |
107 |
$631.28 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
92 |
84 |
$631.26 |
| Z4301 |
|
26 |
26 |
$626.60 |
| 99205 |
Prolong outpt/office vis |
13 |
13 |
$545.85 |
| 95816 |
|
12 |
12 |
$533.17 |
| 87015 |
|
387 |
380 |
$519.06 |
| 80069 |
|
86 |
78 |
$514.02 |
| 82310 |
|
94 |
85 |
$509.32 |
| 76000 |
|
36 |
36 |
$474.15 |
| 76536 |
|
16 |
16 |
$470.85 |
| 82525 |
|
39 |
39 |
$468.67 |
| 84295 |
|
101 |
98 |
$463.87 |
| 97014 |
|
29 |
16 |
$445.70 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
44 |
41 |
$437.69 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
15 |
13 |
$433.50 |
| V5014 |
Repair/modification of a hearing aid |
28 |
28 |
$426.40 |
| S9470 |
Nutritional counseling, dietitian visit |
65 |
64 |
$416.00 |
| 88342 |
|
41 |
39 |
$415.11 |
| 84702 |
|
41 |
39 |
$395.90 |
| 77080 |
|
14 |
14 |
$384.58 |
| 11900 |
|
119 |
118 |
$380.28 |
| 84132 |
|
62 |
61 |
$377.62 |
| 92015 |
Determination of refractive state |
817 |
816 |
$352.42 |
| 72040 |
|
13 |
13 |
$352.04 |
| 84402 |
|
81 |
81 |
$346.57 |
| 88108 |
|
485 |
428 |
$344.65 |
| 89051 |
|
499 |
443 |
$335.69 |
| 84134 |
|
15 |
15 |
$309.75 |
| A4335 |
Incontinence supply; miscellaneous |
174 |
174 |
$308.89 |
| 82105 |
|
16 |
15 |
$298.08 |
| 84520 |
|
815 |
606 |
$294.15 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
198 |
192 |
$285.88 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
257 |
227 |
$285.60 |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
14 |
13 |
$284.76 |
| 86747 |
|
13 |
13 |
$276.90 |
| T1024 |
Evaluation and treatment by an integrated, specialty team contracted to provide coordinated care to multiple or severely handicapped children, per encounter |
14 |
14 |
$261.80 |
| 98967 |
|
227 |
221 |
$258.48 |
| J0688 |
Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg |
99 |
99 |
$255.90 |
| 86628 |
|
15 |
15 |
$251.31 |
| 99366 |
|
149 |
143 |
$248.97 |
| 85240 |
|
12 |
12 |
$236.58 |
| 29450 |
|
20 |
12 |
$229.60 |
| 87328 |
|
148 |
136 |
$226.46 |
| A6250 |
Skin sealants, protectants, moisturizers, ointments, any type, any size |
186 |
186 |
$226.35 |
| 93246 |
|
14 |
13 |
$215.91 |
| 87338 |
|
86 |
86 |
$215.16 |
| 85014 |
|
76 |
74 |
$208.88 |
| 29130 |
|
64 |
63 |
$207.88 |
| 93356 |
|
13 |
13 |
$207.05 |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
32 |
16 |
$201.50 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
12 |
12 |
$197.28 |
| 87329 |
|
147 |
135 |
$192.35 |
| 82945 |
|
498 |
440 |
$162.47 |
| 87181 |
|
148 |
139 |
$158.36 |
| 82085 |
|
25 |
24 |
$150.00 |
| 86038 |
|
27 |
27 |
$149.58 |
| J1720 |
Injection, hydrocortisone sodium succinate, up to 100 mg |
14 |
13 |
$140.78 |
| A7015 |
Aerosol mask, used with dme nebulizer |
27 |
26 |
$140.45 |
| 82746 |
|
25 |
25 |
$139.26 |
| 82390 |
|
12 |
12 |
$138.00 |
| 84157 |
|
481 |
425 |
$137.14 |
| 86308 |
|
69 |
68 |
$127.11 |
| A0425 |
Ground mileage, per statute mile |
156 |
152 |
$124.91 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
180 |
137 |
$122.44 |
| 90686 |
|
53 |
53 |
$115.70 |
| J3535 |
Drug administered through a metered dose inhaler |
39 |
36 |
$66.63 |
| 85018 |
|
100 |
96 |
$62.79 |
| 92060 |
|
32 |
31 |
$58.03 |
| 82272 |
|
13 |
12 |
$47.23 |
| 82533 |
|
12 |
12 |
$41.87 |
| 84681 |
|
12 |
12 |
$39.64 |
| 74000 |
|
27 |
18 |
$25.00 |
| 82627 |
|
13 |
13 |
$14.40 |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
17 |
17 |
$8.00 |
| 36415 |
Collection of venous blood by venipuncture |
22 |
21 |
$0.00 |
| J9250 |
Methotrexate sodium, 5 mg |
14 |
12 |
$0.00 |
| A0999 |
Unlisted ambulance service |
198 |
55 |
$0.00 |
| 36591 |
|
78 |
57 |
$0.00 |
| 0310 |
|
12 |
12 |
$0.00 |
| T4531 |
Pediatric sized disposable incontinence product, protective underwear/pull-on, small/medium size, each |
25 |
24 |
$0.00 |